172 related articles for article (PubMed ID: 1923953)
1. The role of hypothalamic hormones in the pathogenesis of pituitary adenomas.
Asa SL
Pathol Res Pract; 1991 Jun; 187(5):581-3. PubMed ID: 1923953
[TBL] [Abstract][Full Text] [Related]
2. Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone.
Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W
Proc Soc Exp Biol Med; 1990 Mar; 193(3):232-5. PubMed ID: 2106141
[TBL] [Abstract][Full Text] [Related]
3. [Recent trends in the pathophysiology and treatment of pituitary adenomas].
Matsuno A
Brain Nerve; 2009 Aug; 61(8):957-62. PubMed ID: 19697885
[TBL] [Abstract][Full Text] [Related]
4. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
5. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterization of "hyperplasia-adenoma sequence" in the pituitaries of transgenic mice expressing a human growth hormone-releasing factor gene.
Umemura S; Oda K; Utsunomiya H; Sanno N; Itoh J; Katakami H; Osamura RY
Tokai J Exp Clin Med; 1995 Jul; 20(2):71-9. PubMed ID: 8797263
[TBL] [Abstract][Full Text] [Related]
7. The role of hormones, growth factors and their receptors in pituitary tumorigenesis.
Ezzat S
Brain Pathol; 2001 Jul; 11(3):356-70. PubMed ID: 11414477
[TBL] [Abstract][Full Text] [Related]
8. Characterization of rat pituitary cells by their responses to hypothalamic releasing hormones.
Kasahara K; Tasaka K; Masumoto N; Mizuki J; Tahara M; Miyake A; Tanizawa O
Biochem Biophys Res Commun; 1994 Mar; 199(3):1436-41. PubMed ID: 8147887
[TBL] [Abstract][Full Text] [Related]
9. Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis.
Lloyd RV; Jin L; Chang A; Kulig E; Camper SA; Ross BD; Downs TR; Frohman LA
Am J Pathol; 1992 Oct; 141(4):895-906. PubMed ID: 1415483
[TBL] [Abstract][Full Text] [Related]
10. The role of GRH mediated AC-cAMP system in the pathogenesis of human pituitary GH-secreting adenomas.
Shi Y; Deng J; Yin J
Chin Med J (Engl); 1996 Aug; 109(8):603-8. PubMed ID: 9206060
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of pituitary tumor].
Saito S; Yokogoshi Y
Nihon Rinsho; 1993 Oct; 51(10):2572-9. PubMed ID: 8254924
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.
Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W
Endocrinology; 1992 Nov; 131(5):2083-9. PubMed ID: 1425411
[TBL] [Abstract][Full Text] [Related]
13. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro.
van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; Mol JA
Eur J Endocrinol; 1998 Mar; 138(3):309-15. PubMed ID: 9539306
[TBL] [Abstract][Full Text] [Related]
14. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis.
Segal-Lieberman G; Rubinfeld H; Glick M; Kronfeld-Schor N; Shimon I
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E982-8. PubMed ID: 16603725
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin.
Vindeløv SD; Hartoft-Nielsen ML; Rasmussen ÅK; Bendtzen K; Kosteljanetz M; Andersson AM; Feldt-Rasmussen U
Growth Horm IGF Res; 2011 Jun; 21(3):134-9. PubMed ID: 21658592
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic.
Biller BM
Endocrinol Metab Clin North Am; 1994 Sep; 23(3):547-54. PubMed ID: 7805653
[TBL] [Abstract][Full Text] [Related]
17. In vitro thyrotropin-releasing activity of corticotropin-releasing hormone-family peptides in coho salmon, Oncorhynchus kisutch.
Larsen DA; Swanson P; Dickey JT; Rivier J; Dickhoff WW
Gen Comp Endocrinol; 1998 Feb; 109(2):276-85. PubMed ID: 9473372
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic peptides modulate cytosolic free Ca2+ levels and adenylyl cyclase activity in human nonfunctioning pituitary adenomas.
Spada A; Reza-Elahi F; Lania A; Gil-del-Alamo P; Bassetti M; Faglia G
J Clin Endocrinol Metab; 1991 Oct; 73(4):913-8. PubMed ID: 1679762
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone-releasing hormone and pituitary somatotrope proliferation.
Frohman LA; Kineman RD
Minerva Endocrinol; 2002 Dec; 27(4):277-85. PubMed ID: 12511850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
